Putting the Case: How Laboratory Medicine Transforms Healthcare Performance ► Emilie Neukom, Marketing Director, Abbott Diagnostics EMEA
Historically, the diagnostic lab industry has not been good at arguing its case with payors, the medical profession and government. Emilie presents detailed, new research on its role and importance in healthcare systems, based on two indepth projects, covering the USA and ten countries around the world.
This is followed by a panel discussion with operators talking about the issues they face and to overcome them. Panelists include Peter Lednicky, CEO, Alpha Labs, (Central Europe), Willem de Boer, Managing Director, MC Groep and Jeremy Schubert, Divisional VP, Abbott Diagnostics Latin America and Canada
2) Lab Outsourcing: Is the sky the limit?
There is huge potential for the public sector to outsource to private operators but, with a few exceptions, it has not done so yet. A panel discussion on where such outsourcing is occuring, best practice in working with public payors and operators and at how to surmount barriers.
Panelists include Sameh-El Sheikh, CEO, Al Borg on the Middle East market, Jos Lamers, CEO, Unilabs and Dr Gregor Rothe, Marienkrankenhaus, formerly of Synlab, on the German market.
3) Labs in Emerging Markets
The Fleury Model ► Carlos Marinelli, CEO, Fleury
With 2015 revenue of $550m, Fleury is one of the largest diagnostic lab and imaging groups in Brazil and has developed a carefully calibrated series of brands aimed at different consumer groups. Carlos walks us through the model and how it works.
Followed by a discussion on Emerging Market players with Benedikt Von Braunmühl, CEO Synevo, Carlos Marinello, CEO, Fleury and Christine Davey of Healthscope